Rhizocalin is the first two-headed sphingolipid like compound isolated from the sponge Rhizochalina incrustata.1) It has been shown that rhizochalin and its derivatives have antibacterial, selective DNA-damaging, antifungal and cytotoxic activity.1) In addition, accumulating evidence suggests that rhizochalin and its derivatives have potent antitumor activity in human cancer cell lines, including cervical cancer, leukemia, and colon cancer.2,3) However, the underlying mechanisms of its anticarcinogenic activity remain poorly understood.The AMP-activated protein kinase (AMPK), a serine/ theronine kinase present in all eukaryotes, is a sensor of cellular energy status. 4) Since tumor-suppressor genes such as TSC2 and LKB1 function as upstream kinases of AMPK, AMPK is known as an antiproliferative molecule. 5,6) Previous studies have reported that AMPK activators, 5-amino-4-imidazolecarboxamide riboside (AICAR) and metformin, inhibit the cell growth in cultured tumor cells and mouse xenograft models.6-8) AMPK activation also induces apoptosis in cancer cell lines such as neuroblastoma cells, pancreatic cells, glioma cells, and endometrial cancer cells. [9][10][11][12] In addition, AMPK activation by phytochemicals, such as quercetin and 24-hydroxyursolic acid, is involved in apoptosis in colon cancer cell lines 13,14) Therefore, AMPK activation by naturally occurring compounds has attractive potentials for cancer therapy.Here, we have investigated the role of aglycon of rhizochalin (AglRhz), two-headed sphingolipid-like compound isolated from the sponge Rhizochalina incrustata, in the activation of AMPK and induction of apoptosis in HT-29 colon cancer cells. We observed that AglRhz inhibited phosphorylation of p70S6K and its downstream target extracellular signal-regulated kinase (ERK) in a Raptor-dependent manner via AMPK activation. We have also found that AglRhz induced the cleavage of caspase-3 and poly(ADP-ribose) polymerase (PARP), as well as DNA fragmentation, resulting in the induction of apoptosis. In addition, AglRhz inhibited insulin-like growth factor (IGF)-induced cell neoplastic transformation in JB6 Cl41 cells and tumorigenicity in HT-29 cells. Taken together, our findings illustrate that AglRhz has a potent antitumor activity against the HT-29 colon cancer cells and suggests a molecular mechanism that underlies the antitumor activity of AglRhz.
MATERIALS AND METHODS
Reagents and AntibodiesMcCoy's 5A medium, L-glutamine, gentamicin, and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA, U.S.A.). Polyvinyl idene difluoride (PVDF) membrane was obtained from Millipore (Bedford, MA, U.S.A.). 3-[4,5-Dimethylthiazol-2-thiazoyl]-2,5-diphenyltetrazolium bromide (MTT) was from Sigma-Aldrich (St. Louis, MO, U.S.A.). Antibodies against phospho-p70S6K (Thr389), p70S6K, phospho-ERK1/2 (Thr202/Tyr204), ERK1/2, phospho-Raptor (Ser792), phospho-AMPK, cleaved caspase-3, cleaved PARP, caspase-3, and B-cell lymphoma 2 (Bcl-2) were from Cell Signaling Technology Inc. (Beverly, MA, U.S.A.); antibodies...